Skip to content

PRFX

PRF Technologies Ltd.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL

$0.97
−1.14%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue25.5K17.0K86.0K
Cost of Revenue105.0K844.0K16.0K15.0K15.0K
Gross Profit(79.5K)(827.0K)(16.0K)(15.0K)71.0K
Operating Expenses
R&D Expense1.8M1.1M11.7M6.0M4.4M
SG&A Expense5.7M3.0M3.0M3.5M4.4M
General & Admin Expense5.5M3.0M3.0M3.5M4.4M
Selling & Marketing Expense244.5K66.0K
Other Expenses1.2M
Total Operating Expenses8.8M4.2M14.7M9.6M8.9M
Cost and Expenses8.9M5.0M(14.7M)9.6M8.9M
Operating Income (EBIT)(8.9M)(5.0M)(14.7M)(9.6M)(8.9M)
Non-Operating
Interest Income143.5K120.0K101.0K406.0K160.0K
Interest Expense10.0K14.0K384.0K61.0K
Net Interest Income143.5K110.0K87.0K22.0K99.0K
Other Non-Op Income/Expense188.0K(27.0K)93.0K248.0K86.0K
Non-Operating Income (excl Interest)(108.0K)(107.0K)(99.0K)
EBT (Pre-Tax Income)(8.7M)(5.0M)(14.6M)(9.3M)(8.8M)
Income Tax Expense12.0K8.0K8.0K8.0K9.0K
Bottom Line
Net Income(8.4M)(4.8M)(14.6M)(9.3M)(8.8M)
Earnings from Cont. Ops(8.7M)(5.0M)(14.6M)(9.3M)(8.8M)
Earnings from Discont. Ops
Bottom Line Net Income(8.4M)(4.8M)(14.6M)(9.3M)(8.8M)
Per Share
Basic EPS($36.42)($7.47)($804.00)($4,283.23)($4,948.02)
Diluted EPS($36.42)($7.47)($804.00)($4,283.23)($4,948.02)
Revenue Per Share$0.04$0.03$0.00$0.00$48.40
Shares
Basic Shares Outstanding6479736479731814221821777
Diluted Shares Outstanding6479736479731814221821777
Profitability Metrics
EBITDA(7.5M)(4.2M)(14.6M)(9.6M)(8.8M)
D&A1.3M774.0K16.0K15.0K15.0K
EBIT(8.8M)(5.0M)(14.6M)(9.6M)(8.8M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025